EUCTR2006-003003-39-NL进行中（未招募）不适用
Methotrexate versus expectant management in women with ectopic pregnancy (METEX study) - METEX study
Academic Medical Center0 个研究点目标入组 72 人开始时间: 2006年7月17日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 72
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •All hemodynamically stable patients = 18 years with either an ectopic pregnancy (a visible ectopic pregnancy or an ectopic mass on TVS) and a plateauing serum hCG concentration < 1,500 IU/L or with a PUL and a plateauing serum hCG concentration < 2,000 IU/L (persisting PUL) will be eligible for the trial. The difference in serum hCG cut-off levels for these two entities is based on our earlier work.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients with a viable ectopic pregnancy, signs of tubal rupture or active intra abdominal bleeding, and/or abnormalities in liver or renal function or in full blood count will not be included.
研究者
相似试验
已完成
不适用
Methotrexate versus expectant management in women with ectopic pregnancyEctopic pregnancyISRCTN48210491Academic Medical Center (AMC) (The Netherlands)72
已完成
不适用
Methotrexate versus Expectant management in women with ectopic pregnancy.ectopic pregnancyPregnancy of unknown location (PUL)low and plateauing serum hCGmethotrexateexpectant managementNL-OMON25989Academic Medical Center, University of Amsterdam Obstetrics and Gynaecology (H4-205) Meibergdreef 9 1105 AZ AMSTERDAM THE NETHERLANDS tel: +31 20 5663693 fax: +31 20 696348972
尚未招募
4 期
The METEX Study: methotrexate versus expectant management in women with ectopic pregnancyEctopic PregnancyTubal PregnancyNL-OMON30421Academisch Medisch Centrum72
尚未招募
Unknown
Comparing methotrexate and methotrexate with methotrexate with apremilast in modifying biochemical parameters of psoriasis patients.CTRI/2023/03/050882Anisha Biswal
进行中（未招募）
1 期
Impact of concomitant Methotrexate on efficacy, safety and adherence of Ustekinumab-treatment in patients with active Psoriatic Arthritis (MUST-Study)active psoriatic arthritisMedDRA version: 21.0Level: LLTClassification code 10037160Term: Psoriatic arthritisSystem Organ Class: 100000004859EUCTR2015-005777-20-DEFraunhofer Gesellschaft for its Institute Fraunhofer Institute for Translational Medicine and Pharmacology ITMP196